DCGO Stock Forecast 2025-2026
Distance to DCGO Price Targets
DCGO Price Momentum
10 Quality Stocks Worth Considering Now
Researching DocGo (DCGO) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on DCGO and similar high-potential opportunities.
Latest DCGO Stock Price Targets & Analyst Predictions
Based on our analysis of 8 Wall Street analysts, DCGO has a bullish consensus with a median price target of $5.00 (ranging from $2.85 to $8.00). Currently trading at $2.78, the median forecast implies a 79.9% upside. This outlook is supported by 6 Buy, 1 Hold, and 0 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
DCGO Analyst Ratings
DCGO Price Target Range
Latest DCGO Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for DCGO.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Feb 28, 2025 | Stifel | David Grossman | Buy | Maintains | $5.50 |
| Feb 28, 2025 | Needham | Ryan MacDonald | Buy | Maintains | $4.00 |
| Jan 16, 2025 | Needham | Ryan MacDonald | Buy | Reiterates | $7.00 |
| Sep 20, 2024 | Cantor Fitzgerald | Sarah James | Overweight | Reiterates | $5.00 |
| Aug 20, 2024 | Cantor Fitzgerald | Sarah James | Overweight | Reiterates | $5.00 |
| Aug 8, 2024 | Needham | Ryan MacDonald | Buy | Reiterates | $7.00 |
| May 9, 2024 | Needham | Ryan MacDonald | Buy | Maintains | $7.00 |
| May 9, 2024 | BTIG | David Larsen | Buy | Maintains | $7.00 |
| May 9, 2024 | Canaccord Genuity | Richard Close | Buy | Maintains | $5.00 |
| May 9, 2024 | Cantor Fitzgerald | Sarah James | Overweight | Maintains | $5.00 |
| Apr 30, 2024 | Stifel | David Grossman | Buy | Maintains | $6.50 |
| Apr 11, 2024 | Canaccord Genuity | Richard Close | Buy | Maintains | $9.00 |
| Apr 10, 2024 | Stifel | David Grossman | Buy | Maintains | $8.00 |
| Apr 10, 2024 | BTIG | David Larsen | Buy | Maintains | $11.00 |
| Feb 29, 2024 | Needham | Ryan MacDonald | Buy | Maintains | $10.00 |
| Feb 29, 2024 | Canaccord Genuity | Richard Close | Buy | Maintains | $10.00 |
| Feb 29, 2024 | Cantor Fitzgerald | Sarah James | Overweight | Maintains | $11.00 |
| Feb 23, 2024 | Stifel | David Grossman | Buy | Maintains | $11.00 |
| Nov 27, 2023 | Stifel | David Grossman | Buy | Reiterates | $12.00 |
| Oct 2, 2023 | Cantor Fitzgerald | Sarah James | Overweight | Reiterates | $13.00 |
DocGo Inc. (DCGO) Competitors
The following stocks are similar to DocGo based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
DocGo Inc. (DCGO) Financial Data
DocGo Inc. has a market capitalization of $282.49M with a P/E ratio of 15.4x. The company generates $616.56M in trailing twelve-month revenue with a 3.2% profit margin.
Revenue growth is -39.4% quarter-over-quarter, while maintaining an operating margin of -6.2% and return on equity of +4.3%.
Valuation Metrics
Growth & Margins
Financial Health
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
DocGo Inc. (DCGO) Business Model
About DocGo Inc.
Provides mobile and integrated medical care solutions.
DocGo Inc. generates revenue by delivering non-emergency medical services directly to patients, utilizing technology to enhance service efficiency. Their innovative approach includes real-time tracking of medical transportation and remote patient monitoring, which improves patient convenience and strengthens healthcare delivery.
The company plays a significant role in supporting hospital systems and emergency services, particularly in underserved communities. By alleviating pressure on traditional healthcare facilities, DocGo contributes to improving overall healthcare infrastructure and accessibility.
Company Information
Sector
Healthcare
Industry
Medical Care Facilities
Employees
3,404
CEO
Mr. Lee Bienstock
Country
United States
IPO Year
2000
Website
www.docgo.comDocGo Inc. (DCGO) Latest News & Analysis
DocGo Inc. (Nasdaq: DCGO) CEO Lee Bienstock will speak at the Needham Virtual Healthcare Conference on April 7 at 11:45 AM ET, with a webcast available on their investor relations website.
DocGo's CEO participation in a major healthcare conference signals potential insights into the company's strategy and growth, which could influence investor sentiment and stock performance.
DocGo: I'm Still On The Fence On This One
18 days agoDocGo's shares fell over 45% since mid-February, with a 20% drop post-Q4 '24 report. The company is shifting to Health Insurance Partnerships for stable revenue amid declining COVID-related contracts.
DocGo's steep share decline reflects revenue instability and reliance on dwindling COVID-related contracts. The shift to Health Insurance Partnerships may stabilize earnings, but competition poses risks.
Motion Acquisition (DCGO) has received a Zacks Rank #2 (Buy) upgrade, indicating improved earnings prospects, which could lead to a potential increase in the stock price.
The upgrade to Zacks Rank #2 signals increased confidence in Motion Acquisition's earnings potential, likely boosting investor interest and driving the stock price upward.
DocGo, Inc. (NASDAQ: DCGO) will hold its Q4 2024 earnings call on February 27, 2025, at 5:00 PM ET, featuring key company executives and analysts from major financial firms.
DocGo's Q4 2024 earnings call provides insights on financial performance and future guidance, directly impacting share price and investment strategies. Analyst questions can reveal market sentiment.
DocGo Inc. reported 2024 revenue of $616.6 million, down from $624.2 million in 2023. The GAAP gross margin improved to 32.1%, up from 28.7% the previous year.
DocGo's revenue decline may raise concerns about growth prospects, while improved gross margins suggest better cost management, impacting investor sentiment and future valuations.
DocGo Inc. (DCGO) Q4 Earnings Beat Estimates
27 days agoDocGo Inc. (DCGO) reported quarterly earnings of $0.05 per share, surpassing the Zacks Consensus Estimate of $0.04, but down from $0.06 per share year-over-year.
DocGo Inc.'s earnings beat expectations, indicating stronger performance than anticipated. However, the decline from last year's earnings could raise concerns about growth sustainability.
Frequently Asked Questions About DCGO Stock
What is DocGo Inc.'s (DCGO) stock forecast for 2025?
Based on our analysis of 8 Wall Street analysts, DocGo Inc. (DCGO) has a median price target of $5.00. The highest price target is $8.00 and the lowest is $2.85.
Is DCGO stock a good investment in 2025?
According to current analyst ratings, DCGO has 6 Buy ratings, 1 Hold ratings, and 0 Sell ratings. The stock is currently trading at $2.78. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for DCGO stock?
Wall Street analysts predict DCGO stock could reach $5.00 in the next 12 months. This represents a 79.9% increase from the current price of $2.78. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is DocGo Inc.'s business model?
DocGo Inc. generates revenue by delivering non-emergency medical services directly to patients, utilizing technology to enhance service efficiency. Their innovative approach includes real-time tracking of medical transportation and remote patient monitoring, which improves patient convenience and strengthens healthcare delivery.
What is the highest forecasted price for DCGO DocGo Inc.?
The highest price target for DCGO is $8.00 from at , which represents a 187.8% increase from the current price of $2.78.
What is the lowest forecasted price for DCGO DocGo Inc.?
The lowest price target for DCGO is $2.85 from at , which represents a 2.5% increase from the current price of $2.78.
What is the overall DCGO consensus from analysts for DocGo Inc.?
The overall analyst consensus for DCGO is bullish. Out of 8 Wall Street analysts, 6 rate it as Buy, 1 as Hold, and 0 as Sell, with a median price target of $5.00.
How accurate are DCGO stock price projections?
Stock price projections, including those for DocGo Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
